Candel Therapeutics to Present at the SITC 2025 Annual Meeting

Benzinga
2025.10.03 14:07
portai
I'm PortAI, I can summarize articles.

NEEDHAM, Mass., Oct. 03, 2025 ( GLOBE NEWSWIRE ) -- Candel Therapeutics, Inc. ( Candel or the Company ) ( NASDAQ:CADL ) , a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the Company will present ...

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer